Baird analyst Catherine Ramsey Schulte lowered the firm’s price target on Agilent to $136 from $147 and keeps an Outperform rating on the shares. The firm said they cut 2024 revenue/EPS guidance on increased pharma capital spending caution, incremental China weakness, and NASD project timing and Baird is now increasingly cautious on instrumentation/China-exposed tools names.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on A:
- A Earnings: Agilent Tanks 13% after Issuing Weak Guidance
- Options Volatility and Implied Earnings Moves Today, May 29, 2024
- Options Volatility and Implied Earnings Moves This Week, May 28 – May 30, 2024
- Agilent Technologies (A) Q2 Earnings Cheat Sheet
- Early notable gainers among liquid option names on May 10th